Massachusetts Science News (United States)

Biosimilars: Surveying the Market Landscape Report - This report reviews all aspects of biosimilar production, from manufacturing and marketing to the regulatory landscape.

Targeting Parkinson's Disease symposium keynote presenter Kuldip Dave of the Michael J. Fox Foundation conducts a podcast interview on his work with the MJFF and his presentation at the upcoming symopsium.

Those that missed last month's event can get a CD with 350 speaker presentations from 16 conferences within 4 scientific channels: diagnostics, drug discovery & development, informatics and cancer. TriConference.com

This session is the latest addition to CHI’s Tissue-Based Diagnostics Conference, June 4-5, 2012, Philadelphia, PA. Hear a keynote presentation by Guillermo Tearney, M.D., Ph.D., Prof. of Pathology, Harvard Medical School & Mass General Hospital.

Dr. Copeland will present in the druggability and kinetics-based drug design session.

Licensing Strategies of Large Pharmaceutical Companies - Weak R&D Pipelines and the Patent Cliff Stimulate In-Licensing Activity Report

Antibody-Drug Conjugates 2011 – real breakthrough still to come: a Technology, Stakeholder and R&D Pipeline Analysis Report

Hematological Cancer Therapies: Pipelines, Markets, and Business Considerations

Pathology in cancer drug development is one of the sessions taking place at CHI’s inaugural Innovative Tissue-Based Diagnostics: Decoding Cancer & Other Maladies conference being held on June 4-5, 2012 at the Loews Hotel in Philadelphia, PA.

A Two Day Event Focusing on the Challenges in eHealth and Personalized Medicine.

A Two Day Event Focusing on the Challenges in Systems Biology.

A Two Day Event Focusing on the improving the Drug Discovery Process by Optimizing Physical Properties

Those that missed last month's event can get a CD with 80 speaker presentations from 4 pipelines: formulation, purification, biotherapeutics, and expression. Individual track CDs and the overall event CD is available at CHI-PepTalk.com.

A Two Day Event Focusing on the Challenges in Antibacterial Drug Development.

A Two Day Event Focusing on the Challenges in Fragment Based Drug Discovery.

April 18, 2012 | 6:30-9:00 PM | Hilton San Diego Resort | San Diego, CA

Copies of the speakers slides and poster abstracts are available on CD for those that missed this conference that took place on January 10-13, 2012.

Barnett International announced today the launch of an ongoing series of web-based courses focused on SOP development, optimization and standardization.

Barnett International announced today the launch of fourteen new in-person and web-based courses. These new courses were added to further serve the constantly evolving training and educational needs of global clinical research professionals today.

Cambridge Healthtech Institute & Bio-IT World organizes a two hour dinner short course on June 7, 2012, Royal Sonesta Hotel Boston, Cambridge, MA. The course will be held at the conclusion of day two of the Structure-Based Drug Design conference.

Cambridge Healthtech Institute & Bio-IT World organizes a dinner short course on June 6, 2012 at the Royal Sonesta Hotel Boston in Cambridge, MA. The course will be held at the conclusion of day one of the Structure-Based Drug Design conference.

Join us for a roundtable discussion during the Cancer Biologics Conference at the Tri-Conference. Discussion moderated by: Norman J. Maitland, Ph.D., Chief Scientific Officer, Procure Therapeutics Ltd.

Join 150+ delegates involved in IT and informatics at pharma, biotech & academic institutions at CHI’s Molecular Med TRI-CON 2012 event on Feb. 21-23, 2012 at the Moscone North Convention Center in San Francisco, CA. www.TriConference.com/IRD.

Delegates now have the option to choose from 3 moderated breakout discussion groups in the exhibit hall at this conference that is set for February 21-23, Moscone North Convention Center, San Francisco, CA (part of CHI's Molecular Med TRI-CON 2012).

Hear breakthroughs in the field of pathology such as predictive cancer biomarkers, decoding cancer molecular profiles, next generation sequencing, circulating tumor cells, etc. View final agenda at www.healthtech.com/tdx.

Event Focus will be Predicting Biological and Kinetic Profiles from Structure

Delegates now have the option to choose from 3 moderated breakout discussion groups in the exhibit hall at this conference that is set for February 21-23, Moscone North Convention Center, San Francisco, CA (part of CHI's Molecular Med TRI-CON 2012).

Agenda Announcement and Registration Reminder for CHI’s Eighth Annual PEGS the essential protein engineering summit, April 30 – May 4, Boston, MA

Cambridge Healthtech Institute’s Third Annual Anti-Inflammatories: Small Molecule Approaches will be held April 17-18, 2012 in San Diego as part of the Drug Discovery Chemistry conference. Early registration discount expires January 27th.

100+ pharma and biotech companies from around the world will participate at CHI's 4th annual Integrated R&D Informatics & Knowledge Management conference to be held in San Francisco, CA on February 21-23, 2012.

Badri Rengarajan, M.D., Medical Director, will present in the modeling and simulation tools to improve Phase III success session.

The U.S. merchant hydrogen market rose from $3.36 billion in 2010 to $3.44 billion in 2011. By 2016, the market should reach $3.87 billion, yielding a compound annual growth rate (CAGR) of 2.4% for the period.

Dr. Quackenbush will present in the translating biomarker driven cancer treatments into practice session.

Delegates now have the option to choose from 3 moderated breakout discussion groups at this conference that is set for February 21-23, San Francisco, CA (part of CHI's Molecular Med TRI-CON 2012).

Dr. Leach will participate in a keynote session at this conference scheduled for Feb. 21-23, 2012, San Francisco, CA. The conference is organized by Cambridge Healthtech Institute.

Chris Porter, Product Manager, HPC Cloud, will lead a luncheon presentation at CHI’s Cloud Computing: Applications and Advances in Life Sciences R&D Symposium next month in San Francisco, CA.

This Insight Pharma Report focuses on the applications, technology and market aspects of high-content analysis.

Your Asian Glow is a condition in which an individual's face and/or body experiences flushes or blotches as a result of an accumulation of Acetaldehyde, a metabolic byproduct of the catabolic metabolism of alcohol. How to cure Asian Glow...

Janis Research Company is pleased to announce the model JDry-500-TLSV top-loading cryogen-free dilution refrigerator (DR) system with sample in vacuum. The sample base temperature is 20mK-40mK depending on wires and cables installed on sample mount.

Janis Research Company is pleased to announce that it is offering a new series of micro-manipulated probe systems with a rotatable magnetic field. The typical vibration level is +/- 25 nm and the long-term drift is approximately 2 nm/min.

Event Focusing on Novel Small Molecules as Therapeutic Targets

Dr. Craig Jordan announces presentation at upcoming symposium on February 19-20, 2012 in San Francisco, CA.

Cambridge Healthtech Institute to Hold Inaugurual Next-Generation Pathology Symposia at 19th International Molecular Med Tri-CON 2012.

CHI’s Cancer Biologics conference is being held at the Molecular Med TRI-CON 2012 on February 21-23 at the Moscone in San Francisco.

This conference is part of the Molecular Med TRI-CON 2012 event on February 21-23, 2012 at the Moscone North Convention Center in San Francisco, CA. Advance registration discounts ends on January 13.

Dr. Williams will present on evidentiary standards for surrogate endpoints, genetic testing & CDx.

CHI’s Bioinformatics & Cancerinformatics conference is a new program being held at the Molecular Med TRI-CON 2012 on Feb. 21-23 at the Moscone in San Francisco. This conference is part of the many program options available at the Tri-Conference.

Amarin’s CMO to lead line-up of thought leaders at Cambridge Healthtech Institute’s executive and scientific forum.

Webinar shows attendees how to design for the least number of heat sinks and potentially none at all; Thursday, December 15, 2PM EST

CHI confirms new speakers for its keynote session on cancer clinical trials in the era of personalized medicine lead by Roche Holding AG, UCSF Helen Diller Family Comprehensive Cancer Center, and Samuel Oschin Comprehensive Cancer Institute.